Best NAD+ Source: The Weighting a Lifter Should Use

Best NAD+ source is not a claim worth making before the scoring is visible, so the weighting comes first and the ranking second. Seven supplier categories, judged on what a buyer can actually verify from outside, not on which storefront looks the most professional.

The weighting, stated before anything is ranked

Grade and testing carry half of it deliberately. On the peptides covered elsewhere on this site, testing scope alone would sit at the top. NAD+ has a documented upstream failure that testing scope alone does not describe, which is why provenance gets its own column.

Best NAD+ source: seven categories scored against that weighting

Two results in that table are worth arguing with, and both are argued with below: the category that scores second cannot realistically be bought from, and the category most people assume is safest scores fifth.

Why testing scope carries the most weight here

FDA published a notice reminding compounders to use ingredients suitable for sterile compounding, content current as of 10/30/2024. It states the agency "is aware of compounders using food-grade nicotinamide adenine dinucleotide (NAD+) sold by repackagers to make intravenous products," and that food-grade ingredients "are not suitable for compounding sterile drugs without appropriate processing, due to the high risk of contamination with microbes and endotoxins, which can harm patients."

The consequence, in the same notice: FDA "has received adverse event reports following use of NAD+ injectable drugs, including severe chills, shaking, vomiting and fatigue with some requiring medical treatment," reactions the agency called "consistent with excessive levels of endotoxins."

That is why a bacterial endotoxins result is worth more in this scoring than another decimal place of purity. Endotoxin is bacterial debris rather than a live organism, it persists after the organisms that produced it are gone, and it is measured by a separate compendial assay, which FDA treats as its own subject in a questions and answers guidance on pyrogen and endotoxins testing. A seller publishing chromatograms and mass spectra alone has answered a question nobody was injured by.

Why grade sits beside testing rather than underneath it

A test result describes a sample. Provenance describes where the material came from and what it was made for, and the FDA notice is a story about provenance: material produced for food or supplement use, moved through repackagers, and ending up in sterile preparations it was never specified for. FDA in the same notice urged manufacturers and repackagers to "clearly identify any ingredients intended for use in foods or dietary supplements on the label."

Most research listings say nothing about grade. That is why the winning category scores 15 out of 25 on this criterion rather than 25: it is the best available answer in a channel where the field is usually blank, not a full one. Ask the question anyway. A seller who can describe the specification of the material is unusual, and the unusual answers are the informative ones.

What price transparency means when the unit is 100 mg

NAD+ is a coenzyme, not a peptide, and it sells in grams where the rest of this market sells 5 and 10 mg vials. That breaks the per-milligram habit completely: expressed per milligram, a gram at $52.00 reads as five cents, which invites a comparison against peptide pricing that means nothing.

Per 100 mg is the unit that works. $52.00 on a 1,000 mg presentation is $5.20 per 100 mg, and any seller whose page lets you reach that figure in one step scores full marks here. Any seller quoting a total with no quantity scores nothing, regardless of how low the total is. The complete arithmetic, including tiers, is in NAD+ price.

The category that scores second and cannot be bought from

Life-science catalog suppliers, the ones selling reagents to institutions, publish the best documentation in this table. Specifications are stated, grades are explicit, certificates are thorough, and the whole apparatus is built for buyers who will be audited.

They score 78 and are still not the recommendation, because the format is wrong for anyone outside a laboratory. Quantities are small, prices per unit mass are far above the research market, and purchasing usually requires an institutional account and a business shipping address. That is a legitimate channel operating exactly as intended for its own audience, and a scoring table that ignored practicality would rank it first and mislead every reader.

Where clinics and pharmacies actually land

The clinic row scores 32, which will read as harsh for the most supervised route in the market. The scoring is about verifiability, and a clinic hands you almost none of it: the material cost is invisible inside a service price, the compounding source is rarely named, and the certificate is not something a patient is normally shown. Supervision is real value, and it is not what this table measures. The local search version of that question is in NAD+ near me.

The pharmacy row scores 68 because it is genuinely available, unlike on any other compound covered here. NAD appears in FDA's 503A Category 1, "Bulk Drug Substances Under Evaluation," on the category lists updated May 14, 2026, meaning FDA does not intend to act against compounders using it while its guidance conditions are met. That is non-enforcement during an open evaluation and not an approval, and compounded preparations are not approved products. It loses points on price transparency and access friction rather than on quality. The precise legal position is in NAD+ without prescription.

The listing we point to, scored openly

Ascension's NAD+ 1,000 mg sits in the top category. The page lists at $104.00 against a $179.99 reference price, drops to $52.00 with PEPTIDEDECK for $5.20 per 100 mg, and publishes two independent third-party reports for the batch, currently Kovera Labs batch 25-05260628 tested June 14, 2026 and MZ Biolabs batch 25-01260229 tested January 26, 2026. Dispatch is same day before 2pm CST, free shipping starts at $250, and the listing carries research-use-only language and declines to discuss reconstitution or amounts.

Where it does not score full marks is the two criteria this article weights heaviest. Like nearly every listing in the channel, it does not state a grade specification for the raw material, and if the published reports do not include a bacterial endotoxins result then that is the question to put to the seller before ordering. Those are the same two questions we would put to any supplier, and the answers are worth more than the discount. This is a documentation position read from the page rather than a laboratory verification we performed.

The same weighting logic, applied to compounds where the endotoxin story is a general sterility concern rather than a documented one, sits in best MOTS-c source and best BPC-157 source.

What the top of the ranking cannot buy you

A first-place supplier buys confidence about the contents of a container. It does not buy an outcome, and the distinction matters more here than the price does.

NAD+ is central to energy metabolism, and that biochemistry is settled. The step from there to a better training week is not: there is no finished human efficacy trial establishing that exogenous NAD+ improves training capacity in healthy trained people, and the registered trial record is the check on any supplier or clinic implying otherwise. Observational work on declining levels with age, summarised across the published literature, is not the same claim.

For a lifter working through a flat block, the causes with real evidence behind them cost nothing to address and deserve the first pass: sleep debt, an aggressive deficit, accumulated volume without a deload, or lean-mass drift on an incretin drug, which we cover in sleep and myostatin, resistance training and myostatin and myostatin inhibitors and GLP-1 muscle loss. If you are scoring suppliers on the stress and focus side of this market as well, the same weighted method runs in best Selank source.

Frequently asked questions